This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: JIPMER 2017, Subject name: Pharmacology
[{'content': 'New drug approved for treatment of tardive dyskinesia is: \nSelect and explain. \nA. Safinamide, B. Tetrabenazine, C. Valbenazine, D. Deutetrabenazine', 'role': 'user'}, {'content': "Answer: C \nExplanation: Tardive dyskinesia is late symptom which appears on treatment with typical antipsychotic like haloperidol. It occurs due to D2 receptor supersensitivity. Treatment of choice isvalbenazine Tetrabenazine and deutetrabenazine are use in Huntington's chorea. Safinamide is a new MAO B inhibitor which is use for treatment of Parkinson.", 'role': 'assistant'}]